News Author: Michele G. Sullivan Publish date: November 2, 2015
Key clinical point: Even subclinical hyperthyroidism may increase the risk of sudden cardiac death.
Major finding: High free thyroxine in euthyroi...
News Author: Michele G. Sullivan Publish date: November 1, 2015
Weekly infusions of paclitaxel delayed progression in some patients with the very aggressive anaplastic thyroid cancer, a small prospective study dete...
News Author: Michele G. Sullivan Publish date: November 1, 2015
Normalizing maternal thyroid function early in pregnancy may improve obstetric outcomes for women with subclinical hypothyroidism.
News Author: Michele G. Sullivan Publish date: October 29, 2015
News Author: Michele G. Sullivan Publish date: October 28, 2015
News Author: Michele G. Sullivan Publish date: October 27, 2015
News Author: Michele G. Sullivan Publish date: October 24, 2015
The investigational FORMA system seems safe and may be effective in patients with NYHA Class III/IV heart failure and severe tricuspid valve regurgita...
News Author: Michele G. Sullivan Publish date: October 22, 2015
Key clinical point: Radiofrequency ablation and ethanol ablation were similarly effective in treating cystic thyroid nodules.
Major finding: At 6 ...
News Author: Michele G. Sullivan Publish date: October 21, 2015
Key clinical point: Falling thyroglobulin levels cannot predict early response to pazopanib in differentiated thyroid cancers.
Major finding: Ther...
News Author: Michele G. Sullivan Publish date: October 20, 2015
Key clinical point: Cabozantinib improved overall survival in RET-M918T–positive progressive medullary thyroid cancers.
Major finding: Compa...
News Author: Michele G. Sullivan Publish date: October 17, 2015
Key clinical point: Ocrelizumab decreased relapses and new lesions in relapsing remitting MS.
Major finding: Compared with interferon beta-1a, ocr...
News Author: Michele G. Sullivan Publish date: October 15, 2015
Key clinical point: Thrombus aspiration doesn’t reduce microvascular obstruction in subacute STEMI patients undergoing PCI late after sympto...
News Author: Michele G. Sullivan Publish date: October 14, 2015
Key clinical point: Adding routine thrombectomy to PCI doesn’t improve outcomes; in fact, it increases the risk of stroke by 66% at 1 year.<...
News Author: Michele G. Sullivan Publish date: October 14, 2015
Key clinical point: The humanized monoclonal antibody ocrelizumab is the first drug to post positive results for patients with primary progressive...
News Author: Michele G. Sullivan Publish date: September 30, 2015
Key clinical point: Liraglutide added to multiple daily insulin injections lowered HbA1c significantly more than did placebo in patients with type...
